Health Canada Requests Safety Data Profiles For ADHD Stimulant Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Health Canada requests that manufacturers of stimulants to treat attention deficit/hyperactivity disorder submit "thorough" safety data reviews following the suspension of sales in Canada of Shire's Adderall XR